Neil H. Segal
Full Professor(heuristic)
Cancer Immunotherapy and Biomarkers · Oncology
Compare more Oncology professors.
h-index64
i10-index127
Publications310
Citations30,082
Grants
No NSF/NIH grants on record.
Recent Public Signals
- New paper: Phase 2 study of adjuvant botensilimab in combination with balstilimab in patients with microsatellite-stable colorectal cancer and persistent circulating tumor DNA following surgery and chemotherapy. (Journal of Clinical Oncology)2026-05-28
- New preprint: RETRACTED: Circulating tumor DNA status to direct adjuvant immunotherapy for mismatch repair deficient tumors2025-03-12
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-08-26
Data may not be current
Find elsewhere
ORCID: 0000-0002-3047-2303